Southern African Pharmaceutical Regulatory Affairs Association
SAPRAA (Southern African Pharmaceutical Regulatory Affairs Association) is a society of professionals, largely pharmacists, involved in the area of health product/medicine regulation in Southern Africa. The majority of members work in the pharmaceutical industry or are pharmaceutical consultants. The association holds three general meetings per year, one of which is the annual general meeting required by the Constitution.
2022 Meeting Dates
22 April 2022
23 June 2022
25 August 2022
17 November 2022
We would like to hear from you
Any Comments/Ideas/Suggestions regarding:
Industry Related Matters
SAPRAA is an association that caters for the interests of regulatory affairs professionals, whether they are in industry, are consultants or are employed by the government. It organises regular meetings to support the professional development of its members, and to establish closer dialogue with regulatory agencies, such as South African Health Products Authority (SAHPRA), MCAZ, BoMRA, ZAZIBONA and many other medicines and health product regulatory authorities.
It undertakes to establish the best possible environment of dialogue and discussion on regulatory matters between all role players, for the tasks involved to be accomplished professionally and with proficiency.
Mission Accomplished by
Recognising our responsibility to address the needs of our members in all regulatory spheres
Ensuring networking and sound communication when dealing with the regulators, members and other stakeholders
Assess & Analyse
Assessing and analysing documentation and information relating to regulatory matters in applicable regulatory territories
Ensuring continual professional development by holding regular, educational meetings with our members
Ensuring that SAPRAA conducts its responsibilities in an objective, honest and ethical manner to effectively represent member needs
Providing input to members and collating their comments on issues, legislative and technical, to help ensure that these are scientifically based, are workable and will not unduly restrict innovation of our members in their work environment